Researchers compared the safety and efficacy of switching between reference adalimumab and adalimumab biosimilar CT-P17 in active rheumatoid arthritis.
Researchers of a systematic review assessed the evidence of the effect of periodontal therapy on measures of disease activity and inflammatory burden in patients with rheumatoid arthritis.
Researchers analyzed cardiovascular risk comorbidities among patients with rheumatoid arthritis, and the correlation between CV risk and the use of antirheumatic drugs.
Researchers studied the perspectives of patients with rheumatoid arthritis and RA providers to understand the barriers and facilitators regarding coverage of the influenza and pneumococcal vaccines.
Autoantibody positivity and subclinical synovitis are independent predictors of rheumatoid arthritis (RA) among patients presenting with undifferentiated large joint arthritis.
Use of a smartphone application (app) to monitor patient-reported outcomes does not improve satisfaction or disease outcomes in rheumatoid arthritis (RA), but patients are likely to recommend the app.
For the first time, researchers have assessed the relationship of antibody interactions with response to anti-TNF therapy in patients with rheumatoid arthritis.
Using data from the COVID-19 Global Rheumatology Alliance registry, researchers assessed the association between baseline use of DMARDs and COVID-19 outcomes in patients with rheumatoid arthritis.
Study authors assessed malignancy risk among patients with rheumatoid arthritis receiving combination therapy with Janus kinase inhibitors and methotrexate vs MTX alone.
Rheumatoid arthritis (RA) is associated with restrictive and obstructive spirometry patterns, with the strongest associations seen for severe patterns.
